Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
24,13 USD | +6,53% | +4,14% | +136,80% |
Attività
Numero di dipendenti: 85
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Nadim Ahmed
CEO | Chief Executive Officer | 56 | 18/10/21 |
Jeffrey Jones
CTO | Chief Tech/Sci/R&D Officer | 53 | 28/02/22 |
Jacquelyn Sumer
CMP | Compliance Officer | 46 | 15/08/22 |
Chief Tech/Sci/R&D Officer | 57 | 01/01/18 | |
Kevin Johnston
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/22 |
Chad Messer
IRC | Investor Relations Contact | - | 01/03/22 |
Corinne Savill
PRN | Corporate Officer/Principal | 64 | 01/02/17 |
Stephen Andre
HRO | Human Resources Officer | 62 | 01/04/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Chairman | 71 | 01/08/17 | |
Thomas Ebeling
BRD | Director/Board Member | 65 | 01/08/17 |
Stephen Webster
BRD | Director/Board Member | 63 | 01/09/20 |
Nadim Ahmed
CEO | Chief Executive Officer | 56 | 18/10/21 |
Director/Board Member | 52 | 28/02/22 | |
David Ryan
BRD | Director/Board Member | 57 | 01/11/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 57 634 234 | 54 879 379 ( 95,22 %) | 0 | 95,22 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+136,80% | 1,39 Mrd | |
+67,53% | 63,85 Mrd | |
-0,77% | 41,83 Mrd | |
+45,66% | 40,65 Mrd | |
-10,72% | 27,12 Mrd | |
+13,30% | 26,52 Mrd | |
-22,79% | 18,69 Mrd | |
+4,70% | 12,73 Mrd | |
+24,10% | 12,11 Mrd | |
+27,41% | 12,07 Mrd |
- Borsa valori
- Azioni
- Azione CGEM
- Società Cullinan Therapeutics, Inc.